Ichiro Abe 2020. Efficacy and safety of low-dose ipragliflozin, a selective sodium glucose transporter 2 inhibitor, in patients with type 2 diabetes mellitus. International Journal of Allied Medical Sciences and Clinical Research. 4, 3 (Aug. 2020), 376–382. DOI:https://doi.org/10.61096/ijamscr.v4.iss3.2016.376-382.